LoadingLoadingLoadingNet selling: insiders sold $66.2M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $1K to $15K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position and insiders have been net selling.
Sells/Trims (3)
Qube Research
$131.3M
sold
Two Sigma
$84.9M
trimmed
Citadel
$44.8M
trimmed
Sells (3)
Schnitzer Alan D
$35.3M
sold
Toczydlowski Gregory C
$14.0M
sold
Klenk Jeffrey P.
$3.7M
sold
Buys (1)
Sells (1)
Top-trader positions in TRV could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Oct 16, 2026
Financial period
Q3 2026
Earnings per share
$7.43 expected
Revenue
$11.02B expected
Estimates as of Oct 22, 2026
EPS expected
$8.54 to $10.56
Revenue expected
11 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 16, 2026 | $9.18 / $7.43Yahoo Finance | +23.50% beat | $12.41B $11.02B expected | +12.65% beat |
| Jun 30, 2026 | Jul 17, 2026 | $10.04 / $5.39Yahoo Finance | +86.12% beat | $12.15B $10.99B expected | +10.60% beat |
| Mar 31, 2026 | Apr 16, 2026 | $7.71 / $7.08Yahoo Finance | +8.93% beat | $11.92B No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Jan 21, 2026 | $11.13 / $8.80Yahoo Finance | +26.41% beat | $12.43B No estimate | Unavailable |
| Sep 30, 2025 | Oct 16, 2025 | $8.14 / $6.38Alpha Vantage | +27.59% beat | $12.47B No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 17, 2025 | $6.51 / $3.61Alpha Vantage | +80.33% beat | $12.12B No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 16, 2025 | $1.91 / $0.77Alpha Vantage | +148.05% beat | $11.81B No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Jan 22, 2025 | $9.15 / $6.60Alpha Vantage | +38.64% beat | $12.01B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $12.43B | $11.92B | $12.15B | $12.41B |
| Cost of what it sold | $7.67B | $8.15B | $7.71B | $8.34B |
| Gross profit | $4.76B | $3.78B | $4.45B | $4.07B |
| What it spent | ||||
| Sales and admin | $1.54B | $1.54B | $1.56B | $1.58B |
| Other operating costs | $116.0M | $116.0M | — | — |
| Total operating expenses | $1.66B | $1.66B | $1.56B | $1.58B |
| What was left | ||||
| Operating profit | $3.10B | $2.12B | $2.88B | $2.49B |
| Interest on debt | $116.0M | $116.0M | $113.0M | $118.0M |
| Profit before tax | $3.10B | $2.12B | $2.77B | $2.37B |
| Tax | $607.0M | $408.0M | $559.0M | $452.0M |
| Net profit | $2.50B | $1.71B | $2.21B | $1.92B |
| EBITDA | $3.38B | $2.43B | $3.05B | $2.66B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Brookstone Capital Management Sells 14,640 Shares of The Travelers Companies, Inc. $TRV
NeutralOct 24Insider Selling: Travelers Companies (NYSE:TRV) EVP Sells 9,016 Shares of Stock
NeutralOct 23Selective Insurance Gr Q3 2026 Earnings Call Transcript
Leans bullishOct 23The Travelers Companies, Inc. Estimates – NYSE:TRV
NeutralOct 23The Travelers Companies, Inc. Estimates – BOATS:TRV
NeutralOct 23Aviva warns homeowners to batten down the hatches
NeutralOct 23Seaport Therapeutics, Inc. (NASDAQ:SPTX) Stock Has Average Price Target of $37.25 According to Brokerages
NeutralOct 2313,686 The Travelers Companies, Inc. $TRV Shares Bought by Crossmark Global Holdings Inc.
BullishOct 23